Cargando…
AB184. Icariside II induces NO production in human cavernous endothelial cells via the activation of eNOS by miR-155
OBJECTIVE: To investigate the status miR-155 and its targeting eNOS under the stimulation of glucose and age-BSA and to explore the effect of icariside II (ICA II) on the diabetic endothelial dysfunction of human cavernous endothelial cells (HCECs) by using the miR-155 pathway. METHODS: Purified HCE...
Autores principales: | Lei, Hongen, Xu, Yongde, Yang, Bicheng, Gao, Zhezhu, Guan, Ruili, Xin, Zhongcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708711/ http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s184 |
Ejemplares similares
-
AB178. Molecular biology for genitourinary system diseases and sexual dysfunction icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway
por: Li, Huixi, et al.
Publicado: (2015) -
AB176. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
por: Tian, Wenjie, et al.
Publicado: (2015) -
AB037. Icariside II improves human cavernous endothelial cells function by regulating miR-155/eNOS signal pathway
por: Guan, Ruili, et al.
Publicado: (2016) -
AB177. Implications for differentiation of endogenous stem cells: therapeutic effect from icariside II on a rat model of postprostatectomy erectile dysfunction
por: Xu, Yongde, et al.
Publicado: (2015) -
AB239. Icariside II enhances endothelial nitric oxide synthase expression by suppressing miR-155 in diabetic-like human cavernous endothelial cells
por: Guan, Ruili, et al.
Publicado: (2016)